{"originalText": "1+月前，患者因“大便习惯改变、便血”于我院胃肠外科住院治疗，行钡剂灌肠提示乙状结肠占位性病变；上腹部CT提示乙状结肠壁占位性病变；于2015.08.21在全麻上行腹腔镜上腹腔探查术+中转开腹+术中冰冻活检+乙状结肠癌根治术+小肠部分切除术、肠吻合术，术中见肿瘤位于右上腹，与右侧盆壁粘连紧密，同时与部分小肠、膀胱壁粘连，腹腔少量清亮腹水，肿瘤与盆壁粘连分离困难，升结肠、横结肠未见异常，于乙状结肠靠近降结肠处扪及一直径约5X4CM质硬肿块，肿瘤浸透肠壁，与右侧盆壁广泛粘连且紧密，与右侧膀胱壁部分粘连，小肠距回盲部约180CM处与肿瘤粘连，乙状结肠系膜间及根部可扪及肿大淋巴结。手术过程顺利，术后伤口出现感染，予以头孢替安抗感染等治疗，伤口逐渐愈合。术后病检：乙状结肠低分化腺癌侵及浆膜层，肠系膜淋巴结见癌转移（5/6），送检右侧盆壁见癌累及；于2015.09.04予以FOLFOX4（奥沙利铂150MG D1+亚叶酸钙0.3G D1~2+5-FU 0.625G D1~2静脉注射+5-FU 1G D1~2静脉滴入）、2015.09.23予以FOLFOX4（奥沙利铂150MG D1+亚叶酸钙0.3G D1~2+5-FU 0.7G D1~2静脉注射+5-FU 1G D1~2静脉滴入）化疗，化疗过程中无恶心、呕吐等不适，化疗结束后复查血常规未见骨髓抑制；患者今为行进一步治疗于我科住院治疗。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 24}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"label_type": "影像检查", "overlap": 0, "start_pos": 48, "end_pos": 53}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"label_type": "手术", "overlap": 0, "start_pos": 82, "end_pos": 125}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 312, "label_type": "药物", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 331, "end_pos": 340}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 398, "label_type": "药物", "overlap": 0, "start_pos": 394}, {"end_pos": 411, "label_type": "药物", "overlap": 0, "start_pos": 407}, {"end_pos": 425, "label_type": "药物", "overlap": 0, "start_pos": 421}, {"end_pos": 446, "label_type": "药物", "overlap": 0, "start_pos": 442}, {"end_pos": 484, "label_type": "药物", "overlap": 0, "start_pos": 480}, {"end_pos": 497, "label_type": "药物", "overlap": 0, "start_pos": 493}, {"end_pos": 511, "label_type": "药物", "overlap": 0, "start_pos": 507}, {"end_pos": 530, "label_type": "药物", "overlap": 0, "start_pos": 526}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 573, "end_pos": 577}]}
{"originalText": "，缘于入院前2月余因“反复返酸、嗳气7年”就诊我院，，行胃镜检查示：“1.胃窦癌2.慢性萎缩性胃炎”，，病理示：“胃管状腺癌II-III级”，下腹部平扫+，增强示：“胃肿瘤，伴腹腔、腹膜后多发淋巴结肿大”，考虑肿瘤局部较晚期，遂于2015.04.18、2015.05.11、2015.06.02予“安素泰210MGIVGTTD1+奥沙利铂（艾恒）150MGIVGTTD2+希罗达1000MGPOBIDD1-14”方案新辅助化疗，辅以止吐、制酸、保胃、保肝、营养支持等治疗。化疗后未见明显骨髓抑制，一般情况尚可。今为求第4次化疗就诊我院，门诊拟“胃窦癌”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"label_type": "影像检查", "overlap": 0, "start_pos": 71, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 152, "label_type": "药物", "overlap": 0, "start_pos": 149}, {"end_pos": 169, "label_type": "药物", "overlap": 0, "start_pos": 165}, {"end_pos": 172, "label_type": "药物", "overlap": 0, "start_pos": 170}, {"end_pos": 189, "label_type": "药物", "overlap": 0, "start_pos": 186}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 243, "end_pos": 247}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 272, "end_pos": 275}]}
{"originalText": "，缘于入院前23天因“反复中下腹闷痛2周于外院”，行胃镜检查示：糜烂性胃炎（II级），胃角溃疡性质待定。病理（S201439361），：（胃角，活检）粘膜腺癌。遂于2014.11.28于我院行在全麻上行根治性远端胃大部切除术（毕II式，D2)。术顺，术后恢复良好，，术后病理：（201441656），：(远端胃大部)，:胃角溃疡癌变，为管状腺癌II级，其中部分为黏液腺癌，侵及肌层，间质纤维母细胞增生，并多量嗜酸性粒细胞浸浸润，未见明确的脉管内癌栓及神经侵犯，标本双切端均未见癌浸润。找到小弯侧淋巴结12个，大弯侧淋巴结1个，幽门上淋巴结3个，及另送(幽门下）淋巴结1个，(肝总动脉旁）淋巴结3个，(腹腔动脉旁）淋巴结4个，均未见癌转移。，免疫组化：肿瘤细胞示KI67（70%+），P53（+），P170（++），GSTπ（+），EGFR（+），5-FU（+），HER-2（-）。下次出院至今，进食流质膳食可，无恶心、呕吐，无腹痛、腹胀、腹泻，无呕血、黑便等不适，今为进一步复查就诊我院，门诊拟“胃癌术后”收住入院。自发病以来，患者精神、饮食、睡眠可，大小便正常，体重无明显增减。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 42}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "手术", "overlap": 0, "start_pos": 101, "end_pos": 121}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 448, "end_pos": 452}]}
{"originalText": "，缘于入院1年半前无明显诱因感下腹闷痛不适，就诊我院查腹部CT示“，胰头占位:考虑假乳头状”，于2013.04.11在全麻上行“胰头肿物切除、肝肿物切除、小肠憩室切除、胰肠吻合、空肠造瘘术”，术顺，术后病理（201310448），示：肝转移胰腺实性-假乳头状瘤。1.（胰头肿物）胰腺实性-假乳头状瘤，伴出血坏死，侵犯胰腺被摸。另送（肝结节）组织见肿瘤细胞浸润；2.（小肠）送检小肠组织，小肠全层见异位胰腺组织；3.（肝结节）肝转移性胰腺实性-假乳头状瘤。，免疫组化结果：CK(PAN)(++),KI67(6%),SY(+),CD56(+++),CGA(-),CD10(++),CD99(-),E-CADHERIN(-)。今为复查就诊我院，门诊拟胰腺实性假乳头状瘤伴肝转移术后收入院。自发病以来，精神、饮食、睡眠尚可，大小便正常，体重无明显改变。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"label_type": "影像检查", "overlap": 0, "start_pos": 27, "end_pos": 31}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"label_type": "手术", "overlap": 0, "start_pos": 64, "end_pos": 94}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 117, "end_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 149}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 207, "end_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 322, "end_pos": 331}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 332, "end_pos": 337}]}
{"originalText": "患者入院3-月前，因直肠癌于2015-11-17行腹腔镜上直肠癌根治术，术后病检：（直肠）印戒细胞癌，侵及肠周脂肪组织，两侧切缘未见癌累及，肠周围脂肪组织中淋巴结见癌转移（9/13）。术后恢复良好，好转后出院。院外未诉特殊不适，无畏寒、发热、腹痛、腹泻、腹胀、恶心、呕吐等不适。于2015-12-19遵医嘱行第一次化疗，方案为FOLFOX4（奥沙利铂+5-氟尿嘧啶），化疗期间无化疗副反应，复查血常规未见明显异常后出院。院外无特殊不适，无腹痛、腹胀、腹泻、恶心、呕吐等不适。今为行第二次化疗就诊我院，门诊以“直肠癌术后，拟行第二次化疗”收入我科住院治疗。。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 35, "label_type": "手术", "overlap": 0, "start_pos": 25}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 41, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 175, "label_type": "药物", "overlap": 0, "start_pos": 171}, {"end_pos": 182, "label_type": "药物", "overlap": 0, "start_pos": 178}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 254, "end_pos": 259}]}